IT1187828B - Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi - Google Patents

Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi

Info

Publication number
IT1187828B
IT1187828B IT67478/85A IT6747885A IT1187828B IT 1187828 B IT1187828 B IT 1187828B IT 67478/85 A IT67478/85 A IT 67478/85A IT 6747885 A IT6747885 A IT 6747885A IT 1187828 B IT1187828 B IT 1187828B
Authority
IT
Italy
Prior art keywords
treatment
diphosphonates
aretrosis
pharmaceutical composition
composition based
Prior art date
Application number
IT67478/85A
Other languages
English (en)
Other versions
IT8567478A0 (it
Inventor
Sergio Rosini
Luciano Fontanelli
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Priority to IT67478/85A priority Critical patent/IT1187828B/it
Publication of IT8567478A0 publication Critical patent/IT8567478A0/it
Priority to DE3650358T priority patent/DE3650358T2/de
Priority to AT86200822T priority patent/ATE125706T1/de
Priority to EP86200822A priority patent/EP0203649B1/en
Priority to US07/127,191 priority patent/US4814326A/en
Application granted granted Critical
Publication of IT1187828B publication Critical patent/IT1187828B/it
Priority to HK98105381.9A priority patent/HK1006154B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT67478/85A 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi IT1187828B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
DE3650358T DE3650358T2 (de) 1985-05-24 1986-05-13 Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
AT86200822T ATE125706T1 (de) 1985-05-24 1986-05-13 Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
EP86200822A EP0203649B1 (en) 1985-05-24 1986-05-13 Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
US07/127,191 US4814326A (en) 1985-05-24 1987-12-01 Pharmaceutical compositions based on diphosphonates for the treatment of arthrosis and osteoarthritis
HK98105381.9A HK1006154B (en) 1985-05-24 1998-06-16 Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi

Publications (2)

Publication Number Publication Date
IT8567478A0 IT8567478A0 (it) 1985-05-24
IT1187828B true IT1187828B (it) 1987-12-23

Family

ID=11302741

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67478/85A IT1187828B (it) 1985-05-24 1985-05-24 Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi

Country Status (5)

Country Link
US (1) US4814326A (it)
EP (1) EP0203649B1 (it)
AT (1) ATE125706T1 (it)
DE (1) DE3650358T2 (it)
IT (1) IT1187828B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
FI89365C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
EP0522576A3 (en) * 1991-07-12 1993-07-14 Hoechst Aktiengesellschaft Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US6410782B1 (en) * 1997-07-09 2002-06-25 Geange Ltd. Diphosphonic acid salts for the treatment of osteoporosis
US6160165A (en) * 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
DK1178810T3 (da) * 1999-05-21 2005-07-11 Novartis Ag Anvendelse af bisphosphonsyrer til behandling af angiogenese
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
EP1136069A1 (en) * 2000-03-21 2001-09-26 SPA SOCIETA' PRODOTTI ANTIBIOTICI S.p.A. Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration
NZ527157A (en) * 2001-03-01 2005-04-29 Emisphere Tech Inc Compositions for delivering bisphosphonates
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
TWI315982B (en) * 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
ITTO20020406A1 (it) * 2002-05-13 2003-11-13 Chiesi Farma Spa Formulazioni di bisfosfonati ad uso iniettabile.
EP1536803A2 (en) * 2002-05-31 2005-06-08 Kobenhavns Universitet Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
ITMI20052515A1 (it) 2005-12-29 2007-06-30 Abiogen Pharma Spa Formulazione farmaceutica per il trattamento della osteoartrite
CN101932306A (zh) * 2008-02-05 2010-12-29 阿特维斯集团公司 阿仑膦酸盐制剂、其制备方法和使用方法
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
EP4360627A1 (fr) * 2022-10-26 2024-05-01 Institut National de la Santé et de la Recherche Médicale (INSERM) Traitement de l'arthrose par des inhibiteurs de comt

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA777769A (en) * 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
US3471406A (en) * 1965-09-07 1969-10-07 Plains Chem Dev Co Detergent compositions containing methane tri and tetra phosphonic acid compounds
CA790610A (en) * 1965-12-28 1968-07-23 T. Quimby Oscar Diphosphonate compounds and detergent compositions
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
GB1421064A (en) * 1973-03-09 1976-01-14 Procter & Gamble Oral compositions for calculus retardation
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
US4330530A (en) * 1980-12-22 1982-05-18 The Procter & Gamble Company Anti-arthritic compositions and method using gold salts and organophosphonates
IT1194748B (it) * 1981-02-12 1988-09-28 Gentili Ist Spa Composizioni farmaceutiche per il trattamento di osteopatie
EP0088462A3 (en) * 1982-03-01 1984-06-06 The Procter & Gamble Company Anti-inflammatory and rheumatic composition containing organophosphonate and steroid
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate

Also Published As

Publication number Publication date
DE3650358D1 (de) 1995-09-07
EP0203649A2 (en) 1986-12-03
ATE125706T1 (de) 1995-08-15
EP0203649B1 (en) 1995-08-02
HK1006154A1 (en) 1999-02-12
IT8567478A0 (it) 1985-05-24
US4814326A (en) 1989-03-21
EP0203649A3 (en) 1989-12-06
DE3650358T2 (de) 1995-12-21

Similar Documents

Publication Publication Date Title
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
ZA909762B (en) Process for the production of biologically active protein
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
FI920026A0 (fi) Farmaceutisk komposition anvaendbar som avmagringsmedicin.
NO852872L (no) Fremgangsmaate for fremstilling av nye tetrapyrroler.
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
DE69516540D1 (de) AMINO-IMIDAZO [4,5-c] CHINOLINE
BR0108401A (pt) Análogos de nucleosìdeos com base bicìclica modificada por carboxamidina
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
SE8802569D0 (sv) Improvements in or relation to somatostatins
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
SE8303003D0 (sv) Medel for att oka antitumorverkan hos antitumormedel
DE3852935D1 (de) Substituierte Alpha-Aminosäuren mit pharmazeutischer Aktivität.
ATE320270T1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
NO863027D0 (no) Peptidpreparater med kontinuerlig avgivelse.
DE3877277D1 (de) Injektionszusammensetzung, die modifiziertes tpa enthaelt.
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
ATE46347T1 (de) Immunostimulierende peptide.
ATE58829T1 (de) Mittel mit kontinuierlicher freisetzung von phenylethanolaminderivaten.
DK15088D0 (da) Antibakterielt lyofiliseret praeparat
IT8520712A0 (it) Formulazioni farmaceutiche per stimolare la liberazione di ormone somatotropo.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970528